EMMESSACommodity Chemicals
Emmessar Biotech & Nutrition Ltd — Cash Flow Statement
₹23.56
+0.17%
Emmessar Biotech & Nutrition Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 0.22 Cr | 0.64 Cr | 0.35 Cr | 1.96 Cr | — |
| End Cash Position | 0.01 Cr | 0.01 Cr | 0.01 Cr | 0.18 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 1000.00 | -1000.00 | — | 1000.00 | -1000.00 |
| Beginning Cash Position | 0.01 Cr | 0.01 Cr | 0.18 Cr | 0.53 Cr | — |
| Changes In Cash | -25000.00 | 11000.00 | -0.17 Cr | -0.34 Cr | — |
| Financing Cash Flow | 35000.00 | 0.00 | — | — | — |
| Net Other Financing Charges | 41000.00 | — | — | — | — |
| Interest Paid Cff | -6000.00 | 0.00 | — | — | — |
| Investing Cash Flow | -0.23 Cr | -0.64 Cr | -0.55 Cr | -2.61 Cr | — |
| Net Other Investing Changes | 1000.00 | 1000.00 | -20000.00 | 99000.00 | — |
| Interest Received Cfi | 0.46 Cr | 0.35 Cr | 0.26 Cr | 0.14 Cr | — |
| Net Investment Purchase And Sale | -0.69 Cr | -0.99 Cr | -0.78 Cr | -2.46 Cr | — |
| Purchase Of Investment | -0.69 Cr | -0.99 Cr | -0.78 Cr | -2.46 Cr | — |
| Net PPE Purchase And Sale | 0.00 | 0.00 | -0.03 Cr | -0.31 Cr | — |
| Purchase Of PPE | 0.00 | 0.00 | -0.03 Cr | -0.31 Cr | — |
| Operating Cash Flow | 0.22 Cr | 0.64 Cr | 0.38 Cr | 2.27 Cr | — |
| Taxes Refund Paid | -0.02 Cr | 0.02 Cr | 0.06 Cr | -0.29 Cr | — |
| Change In Working Capital | -0.34 Cr | 0.24 Cr | -0.50 Cr | 1.76 Cr | — |
| Change In Other Current Liabilities | -0.10 Cr | 0.02 Cr | 0.08 Cr | -0.38 Cr | — |
| Change In Payable | -58000.00 | 91000.00 | -0.02 Cr | -0.47 Cr | — |
| Change In Inventory | -0.03 Cr | 0.05 Cr | -0.07 Cr | -9000.00 | — |
| Change In Receivables | -0.21 Cr | 0.11 Cr | -0.53 Cr | 2.57 Cr | — |
| Other Non Cash Items | -0.47 Cr | -0.52 Cr | -0.25 Cr | -0.22 Cr | — |
| Depreciation And Amortization | 0.10 Cr | 0.10 Cr | 0.09 Cr | 0.09 Cr | — |
| Depreciation | 0.10 Cr | 0.10 Cr | 0.09 Cr | 0.09 Cr | — |
| Net Income From Continuing Operations | 0.96 Cr | 0.81 Cr | 0.97 Cr | 0.93 Cr | — |
| Capital Expenditure | — | — | -0.03 Cr | -0.31 Cr | -18000.00 |
| Change In Other Current Assets | — | — | — | 0.00 | 0.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Emmessar Biotech & Nutrition Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.